22-17108712-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_014339.7(IL17RA):​c.1493C>T​(p.Thr498Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000312 in 1,610,746 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0016 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00017 ( 2 hom. )

Consequence

IL17RA
NM_014339.7 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 2.33

Publications

3 publications found
Variant links:
Genes affected
IL17RA (HGNC:5985): (interleukin 17 receptor A) Interleukin 17A (IL17A) is a proinflammatory cytokine secreted by activated T-lymphocytes. It is a potent inducer of the maturation of CD34-positive hematopoietic precursors into neutrophils. The transmembrane protein encoded by this gene (interleukin 17A receptor; IL17RA) is a ubiquitous type I membrane glycoprotein that binds with low affinity to interleukin 17A. Interleukin 17A and its receptor play a pathogenic role in many inflammatory and autoimmune diseases such as rheumatoid arthritis. Like other cytokine receptors, this receptor likely has a multimeric structure. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2014]
IL17RA Gene-Disease associations (from GenCC):
  • immunodeficiency 51
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • chronic mucocutaneous candidiasis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.016970754).
BP6
Variant 22-17108712-C-T is Benign according to our data. Variant chr22-17108712-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 476362.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00164 (250/152368) while in subpopulation AFR AF = 0.00577 (240/41592). AF 95% confidence interval is 0.00517. There are 1 homozygotes in GnomAd4. There are 116 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL17RANM_014339.7 linkc.1493C>T p.Thr498Ile missense_variant Exon 13 of 13 ENST00000319363.11 NP_055154.3
IL17RANM_001289905.2 linkc.1391C>T p.Thr464Ile missense_variant Exon 12 of 12 NP_001276834.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL17RAENST00000319363.11 linkc.1493C>T p.Thr498Ile missense_variant Exon 13 of 13 1 NM_014339.7 ENSP00000320936.6
IL17RAENST00000612619.2 linkc.1391C>T p.Thr464Ile missense_variant Exon 12 of 12 5 ENSP00000479970.1

Frequencies

GnomAD3 genomes
AF:
0.00162
AC:
247
AN:
152250
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00571
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.000433
AC:
107
AN:
247104
AF XY:
0.000343
show subpopulations
Gnomad AFR exome
AF:
0.00617
Gnomad AMR exome
AF:
0.000174
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000329
GnomAD4 exome
AF:
0.000173
AC:
253
AN:
1458378
Hom.:
2
Cov.:
65
AF XY:
0.000139
AC XY:
101
AN XY:
725706
show subpopulations
African (AFR)
AF:
0.00595
AC:
199
AN:
33470
American (AMR)
AF:
0.000291
AC:
13
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26122
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86234
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50214
Middle Eastern (MID)
AF:
0.000520
AC:
3
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111836
Other (OTH)
AF:
0.000530
AC:
32
AN:
60346
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00164
AC:
250
AN:
152368
Hom.:
1
Cov.:
34
AF XY:
0.00156
AC XY:
116
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.00577
AC:
240
AN:
41592
American (AMR)
AF:
0.000261
AC:
4
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68038
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
15
29
44
58
73
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000806
Hom.:
0
Bravo
AF:
0.00190
ESP6500AA
AF:
0.00545
AC:
24
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000494
AC:
60
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Immunodeficiency 51 Uncertain:1Benign:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IL17RA NM_014339.6 exon 13 p.Thr498Ile (c.1493C>T): This variant has not been reported in the literature but is present in 0.5% (146/24748) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/22-17589602-C-T?dataset=gnomad_r2_1). This variant is present in ClinVar (Variation ID:476362). Evolutionary conservation suggests that this variant may not impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.57
D;.
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.79
T;T
M_CAP
Benign
0.031
D
MetaRNN
Benign
0.017
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.2
M;.
PhyloP100
2.3
PrimateAI
Benign
0.30
T
PROVEAN
Uncertain
-2.6
D;.
REVEL
Benign
0.12
Sift
Benign
0.058
T;.
Sift4G
Uncertain
0.051
T;T
Polyphen
0.72
P;.
Vest4
0.34
MVP
0.30
MPC
0.72
ClinPred
0.059
T
GERP RS
-0.86
Varity_R
0.13
gMVP
0.56
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41529049; hg19: chr22-17589602; API